Listed

Angiodynamics Inc

ANGONasdaqCIK 1275187HealthcareFiscal year ends May 31

Reports and events: 312 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Angiodynamics Inc, Reports and events
FiledFormWhat it isAccession number
2023-07-1207:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-23-034123
2023-06-1416:39 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001140361-23-029854
2023-06-0817:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001140361-23-028985
2023-06-0207:00 ET8-K8.01 Other events0001140361-23-027896
2023-04-1707:21 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-23-018553
2023-03-3114:32 ET10-QQuarterly reportPeriod 2023-02-280001628280-23-010093
2023-03-3007:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-23-000149
2023-03-0607:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-23-000145
2023-02-2712:14 ET8-K8.01 Other events0000914121-23-000135
2023-01-1207:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-23-000011
2023-01-0616:55 ET10-QQuarterly reportPeriod 2022-11-300001275187-23-000005
2023-01-0507:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-23-000003
2022-11-3007:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001140361-22-043590
2022-11-2308:33 ET8-K8.01 Other events0001140361-22-042873
2022-11-0416:21 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000914121-22-004127
2022-10-1116:27 ET10-QQuarterly reportPeriod 2022-08-310001275187-22-000026
2022-10-0615:46 ET8-K8.01 Other events0000914121-22-004106
2022-10-0607:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-22-004104
2022-09-2210:16 ETDEF 14AProxy statementPeriod 2022-05-310001275187-22-000021
2022-08-3117:26 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000914121-22-004083
2022-08-1007:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-22-004074
2022-07-2215:01 ET10-KAnnual reportPeriod 2022-05-310001275187-22-000017
2022-07-1208:04 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-22-004052
2022-04-0716:14 ET10-QQuarterly reportPeriod 2022-02-280001275187-22-000010
2022-04-0707:22 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-22-002826
2022-01-1007:35 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-22-000132
2022-01-0712:26 ET10-QQuarterly reportPeriod 2021-11-300001275187-22-000005
2022-01-0607:18 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-22-000084
2021-12-0608:00 ET8-K8.01 Other events0000914121-21-007590
2021-11-0316:31 ET8-K5.07 Shareholder vote results0000914121-21-007073
2021-09-3016:37 ET10-QQuarterly reportPeriod 2021-08-310001275187-21-000023
2021-09-3007:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-21-006377
2021-09-2212:27 ETDEF 14AProxy statementPeriod 2021-05-310001275187-21-000017
2021-07-2713:54 ET10-KAnnual reportPeriod 2021-05-310001275187-21-000013
2021-07-1308:47 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-21-004918
2021-07-1306:54 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure0000914121-21-004916
2021-05-2506:55 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-21-003853
2021-04-1206:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-21-002530
2021-03-3112:09 ET10-QQuarterly reportPeriod 2021-02-280001275187-21-000008
2021-03-3007:14 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-21-001868
2021-03-0908:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-21-001492
2021-02-0316:27 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000914121-21-000581
2021-01-1114:32 ET8-K7.01 Regulation FD disclosure0000914121-21-000070
2021-01-0812:06 ET10-QQuarterly reportPeriod 2020-11-300001275187-21-000005
2021-01-0716:15 ET8-K/A7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-21-000060
2021-01-0707:10 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-21-000046
2020-11-1906:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-20-004172
2020-10-1508:01 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000914121-20-003700
2020-10-0716:18 ET10-QQuarterly reportPeriod 2020-08-310001275187-20-000034
2020-09-2907:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000914121-20-003469

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.